로딩 중…
StockDiggingStockDigging

Enovis Corporation

ENOV· NYSE
$31.42+7.79%
2026-08-03

Financials

Valuation Metrics

Enovis Corporation's Market Cap is $1.81B. At end of 2025 it was $1.51B. Ranked #2127 of 3,112 in US market (top 68%), #1302 of 1,667 on NYSE (top 78%), #125 of 206 in Health Care Equipment & Services (top 61%) by Market Cap.

Investment Metrics(as of 2026-08-03)

MetricValue
Size
Market Cap$1.81B
Revenue$2.28B
Net Income$-1.14B
Total Assets$3.83B
Net Assets$1.48B
Employees7,802
Value
P/B1.22x
P/S0.79x
FCF Yield1.99%
Profitability
ROE-77.00%
ROA-29.68%
Op. Margin2.70%
Revenue Growth5.42%
Financial Health
Debt Ratio159.30%
Total Debt$1.41B
FCF$36M
Cash$33M
Current Ratio2.04x
Performance
1Y Return22.07%
1M Return39.64%
From 52W High-8.34%
1Y MDD-44.24%
Trading
Volume1,379,937 shares
Trading Value$43M
Per Share
EPS$-20.86
BPS$26.23

Company Info

CEO Mr. Damien McDonald
Employees 7,802
HQ Wilmington, United States

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.